W. L. Gore & Associates Completes Acquisition of Conformal Medical
Feb 19, 2026
Acquisition expands Gore’s cardiac portfolio through a high-growth adjacency
CAUTION: Investigational Device. Limited by federal (or United States) law to investigational use. Outside the United States, the device is intended exclusively for clinical investigation. Not approved for commercial use.
NEWARK, Del. (February 19, 2026) — W. L. Gore & Associates, Inc. (Gore) a global materials science company, today announced it has completed the acquisition of Conformal Medical, developer of the investigational CLAAS® AcuFORM™ System, a next-generation left atrial appendage occlusion (LAAO) technology. Gore announced its intent to acquire the company in January 2026.
“With this acquisition now complete, we are further strengthening Gore’s product development pipeline in endovascular treatment, with the goal of reaching more patients,” said Bret Snyder, board chair and CEO of W. L. Gore & Associates. “We are delighted to officially welcome Conformal Medical to our Enterprise.”
As a wholly owned subsidiary of Gore, Conformal Medical’s focus will remain on advancing its investigational technology and conducting clinical studies as planned.
“Joining the Gore Enterprise represents an important next chapter for Conformal Medical,” said James Reinstein, President and CEO of Conformal Medical. “Gore’s experience in medical technology development and its commitment to innovation will enable us to benefit from their science-driven approach and long-time commitment to improving patient care.”
Gore has been an innovator in medical technology for 50 years, engineering devices that treat a range of cardiovascular and other health conditions. With more than 50 million medical devices implanted, Gore builds on its legacy of improving patient outcomes through research, education, and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration is improving lives. goremedical.com
About Gore
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With approximately 13,000 Associates and a strong, team-oriented culture, Gore generates annual revenues of $5 billion. For more information, visit gore.com.
About Conformal Medical
Conformal Medical, Inc. is a medical device company developing devices to prevent stroke in patients with non-valvular atrial fibrillation. The company’s proprietary technology is intended to make left atrial appendage closure a same-day, single-operator procedure. For more information, visit conformalmedical.com.